Posted by Michael Wonder on 18 Aug 2021
Talks to recover reimbursement for dementia treatment aid almost complete
18 August 2021 - The negotiations on retrieving the reimbursement of pharmaceutical pricing for choline alfoscerate drugs to help treat dementia between the state health insurance agency and pharmaceutical companies have been concluded except for some drug makers.
After lengthy bargaining, the National Health Insurance Service said that 44of 58 choline alfoscerate makers reached an agreement on 10 August 2021.
